Research Library
A4 Amyloid Beta research
6 articles to explore, with links to 8 original sources.
About A4 Amyloid Beta
“A4 Amyloid Beta” appears to refer to the amyloid-beta protein family used in neurodegeneration research. The label does not specify peptide length, sequence, or aggregation state, which materially change experimental interpretation.
Understand the science
How Cells Make Amyloid Beta From a Larger Protein
The catalog name A4 Amyloid Beta does not specify which fragment or physical form is present. That matters because a 40-amino-acid peptide, a 42-amino-acid peptide, and a clump of those peptides are different experimental materials.
2 sources (2026)
How Small Amyloid Beta Clusters Help Aggregation Spread
Amyloid beta 42, or Aβ42, can be studied as a single chain, as part of a small cluster called an oligomer, or as part of a long fibril. Those states can coexist and change during an experiment.
2 sources (2026)
Explore study findings
Why Amyloid Beta Fibrils Can Have Different Shapes
Amyloid beta is a family of peptides cut from amyloid precursor protein. Some forms can assemble into long fibers, called fibrils, in which many copies of the peptide align. A label such as A4 Amyloid Beta leaves both the sequence and whether the peptide is already assembled unspecified.
1 source (2026)
What Amyloid Beta Ratios in Blood Can Reveal Before a Scan Changes
The amyloid beta family includes Aβ42 and Aβ40, two products of the same precursor that differ in length. The ratio of those two forms in plasma is a measurement of circulating peptides. An amyloid PET scan, by contrast, measures a tracer signal associated with deposited amyloid in the brain.
2 sources (2026)
What Donanemab Follow Up Teaches About Targeting Amyloid Beta
Amyloid beta is a family of peptides produced from a larger membrane protein. Some forms build up in deposits called plaques. Donanemab is an antibody that targets a form of amyloid beta in those deposits. It is the intervention in the research described here; amyloid beta is the target.
1 source (2025)
What a Rare APP Mutation Reveals About Amyloid in Brain Blood Vessels
Amyloid beta is cut from amyloid precursor protein, or APP, so a change in the gene for APP can change the peptide itself. A rare inherited variant called the Flemish mutation changes position 21 in Aβ from alanine to glycine.
1 source (2026)
